Clinical Research Directory
Browse clinical research sites, groups, and studies.
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
Sponsor: NYU Langone Health
Summary
The research team will evaluate the effectiveness of an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.
Official title: Active Choice Clinical Decision Support: Hepatocellular Carcinoma Screening in Patients With Cirrhosis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1300
Start Date
2024-11-20
Completion Date
2026-07-24
Last Updated
2026-02-27
Healthy Volunteers
No
Conditions
Interventions
Auto-pended bot liver ultrasound order
This alert prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.
Locations (1)
NYU Langone Health
New York, New York, United States